Answers are grounded in this paper and cite their sources.
Background Lung cancer is one of the deadliest cancers worldwide, creating a pressing need to develop novel drugs that inhibit oncogenic signaling pathways. Numerous studies have shown that berberine (BBR) has anti–lung cancer potential. We aimed to explore the anti–lung cancer effect of BBR and related mechanisms by targeting the glycogen synthase kinase 3β (GSK3β)/β-catenin pathway. Methods Lung adenocarcinoma (LUAD) cells A549 and NCI-H1975 were treated with BBR. Results Our results showed that BBR inhibited cell proliferation by decreasing c-Myc levels and induced cell cycle arrest in the G0/G1 phase by lowering cyclin D1 levels. BBR induced apoptosis by upregulating cleaved caspase 3 levels. BBR inhibited cell migration and invasion by decreasing N-cadherin levels. Furthermore, BBR upregulated the expression of GSK3β protein and phospho-β-catenin proteins in the cytoplasm, while decreasing the expression of β-catenin protein. Next, LUAD cells were exposed to CHIR-99021 (a GSK3β inhibitor). This treatment led to an increase in c-Myc, cyclin D1, and β-catenin levels at specific concentrations. BBR partially reversed the effects of CHIR-99021. Finally, LUAD cells were treated with CHIR-99021 (4 μmoL/L) combined with BBR (30 and 60 μmoL/L) for 24 h. The expression of programmed death ligand 1 (PD-L1) was assessed by Western blot analysis. Jurkat T cells and A549 cells were co-cultured for 24 h to examine the lactate dehydrogenase release rate. Results suggested that BBR suppressed the expression of PD-L1 and heightened the immune lethality of T cells. Conclusions BBR suppressed the proliferative activity of LUAD cell lines A549 and NCI-H1975 in vitro, induced cell cycle arrest and cancer cell apoptosis in the G0/G1 stage, and repressed the migration and invasion of cancer cells. BBR reduced the PD-L1 protein expression and enhanced T-cell–mediated cytotoxicity. These effects appear to be related to BBR’s regulation of the GSK3β/β-catenin pathway.
No takes yet. Share an insight, caveat, or question.
Wangmu et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: